Artery cleanout without plastic patches: new surgery shows promise

NCT ID NCT03357185

First seen Jun 10, 2026 · Last updated Jun 21, 2026 · Updated 3 times

Summary

This study tested a surgical technique called femoral tripod eversion to treat blocked leg arteries. 37 patients with moderate to severe symptoms were followed for two years. The procedure removes plaque without using artificial material, which may reduce infection risk. The goal was to see if the technique is safe and effective long-term.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATHEROMATOUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Hôpital NOVO

    Cergy-Pontoise, 95300, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Femoral eversion surgery (a procedure to clean out plaque from the leg artery without using artificial material)

What this could lead to

If successful, this technique could offer a safe, durable option for treating blocked leg arteries without leaving permanent synthetic material in the body.

What could go wrong

This is a small, single-center study with only 37 patients and no comparison group. Results may not apply to broader populations, and long-term benefits remain uncertain.

Conditions

The condition(s) this trial relates to.

arteriosclerosis obliterans atherosclerosis peripheral arterial disease Plaque, Atherosclerotic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.